|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Product development expenses | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Amortization and impairment of intangible assets | |||||
| Impairment of goodwill | |||||
| Other gains, net | |||||
| Income from operations | |||||
| Interest and investment income, net | |||||
| Interest expense | |||||
| Other income, net | |||||
| Income before income tax and share of results of equity method investees | |||||
| Income tax expenses | |||||
| Share of results of equity method investees | |||||
| Net income | |||||
| Net loss attributable to noncontrolling interests | |||||
| Net income attributable to Alibaba Group Holding Limited | |||||
| (Accretion) Reversal of accretion of mezzanine equity | |||||
| Net income attributable to ordinary shareholders | |||||
| Earnings per share attributable to ordinary shareholders | |||||
| Basic | |||||
| Diluted | |||||
| Earnings per ADS attributable to ordinary shareholders (one ADS equals eight ordinary shares) | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average number of shares used in computing earnings per share (million shares) | |||||
| Basic | |||||
| Diluted |
Loading...
